Abiopharma

News list

📋 BELANOFF JOSEPH K (Officer) plans to sell 40K shares of CORCEPT THERAPEUTICS INC (at $46.52 each, total $1.9M) Filed: May 01, 2026 | ID: 000014

Full text

News bot May 1, 2026, 4:30 p.m.
📋 Form 144 Filing: BELANOFF JOSEPH K

Company: CORCEPT THERAPEUTICS INC

Filing Date: 2026-05-01

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 40,000
- Price per Share: $46.52
- Total Value: $1,860,800.00
- Planned Sale Date: 2026-05-01
- Broker: Stifel Nicolaus & Company Inc.
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-50679
- Issuer Contact Phone: 650.688.8803
- Issuer Address: 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Broker Address: 501 N Broadway, St. Louis, MO, 63102
- Shares Outstanding: 107360000.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Toni Dobel, as a duly authorized representative of STIFEL, as attorney-in-fact for Joseph K. Belanoff